Hubei Biocause Heilen Pharmaceutical Co., Ltd. Share Price
Equities
301211
CNE100005782
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.04 CNY | -2.20% | -6.25% | -26.25% |
Sales 2022 | 515M 71.11M 5.56B | Sales 2023 | 663M 91.56M 7.15B | Capitalization | 6.26B 865M 67.58B |
---|---|---|---|---|---|
Net income 2022 | 126M 17.4M 1.36B | Net income 2023 | 176M 24.3M 1.9B | EV / Sales 2022 | 12.4 x |
Net cash position 2022 | 1.95B 270M 21.09B | Net cash position 2023 | 1.82B 251M 19.61B | EV / Sales 2023 | 6.71 x |
P/E ratio 2022 |
66.6
x | P/E ratio 2023 |
35.7
x | Employees | 1,012 |
Yield 2022 |
1.15% | Yield 2023 |
2.21% | Free-Float | 24.56% |
1 day | -2.20% | ||
1 week | -6.25% | ||
Current month | -2.20% | ||
1 month | -8.03% | ||
3 months | -11.14% | ||
6 months | -31.98% | ||
Current year | -26.25% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Hao Yi
DFI | Director of Finance/CFO | 51 | 25/06/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ren Hui Fu
BRD | Director/Board Member | 44 | 19/04/23 |
Zhi Gang Cheng
CHM | Chairman | 50 | 25/06/20 |
Xue Qiang Huang
BRD | Director/Board Member | 57 | 25/06/20 |
Date | Price | Change | Volume |
---|---|---|---|
03/06/24 | 16.04 | -2.20% | 1,807,860 |
31/05/24 | 16.4 | +0.18% | 1,450,820 |
30/05/24 | 16.37 | +0.18% | 1,434,740 |
29/05/24 | 16.34 | +0.06% | 1,384,960 |
28/05/24 | 16.33 | -1.57% | 1,811,740 |
End-of-day quote Shenzhen S.E., June 02, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-26.25% | 652M | |
+42.60% | 739B | |
+32.34% | 598B | |
-5.74% | 353B | |
+17.79% | 318B | |
+3.37% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.74% | 164B |
- Stock Market
- Equities
- 301211 Stock